Table 1.
Demographic, clinical, and biochemical characteristics of ESRD patients included in the study.
| Variables | Normal Value | Mean ± Standard Deviation |
|---|---|---|
| Age (years) | >18 | 63.05 ± 11.74 |
| Length of hemodialysis treatment | >6 months | 5.68 ± 5.23 years |
| Gender | men/women | 63/45 |
| Leukocytes | (3.70–10.0 × 109/L) | 7.22 ± 3.46 |
| Erythrocytes | (3.86–5.08 × 10¹²/L) | 3.74 ± 1.23 |
| Hemoglobin | (110–157 g/L) | 102.90 ± 12.32 |
| Platelets | (135–450 × 109/L) | 183.86 ± 64.03 |
| Iron | (6.6–26.0 μmol/L) | 10.78 ± 5.26 |
| Sodium | (136–145 mmol/L) | 138.72 ± 2.98 |
| Potassium | (3.4–4.5 mmol/L) | 5.24 ± 0.82 |
| Calcium | (2.02–2.65 mmol/L) | 2.27 ± 0.20 |
| Phosphorus | (0.80–1.60 mmol/L) | 1.53 ± 0.49 |
| Magnesium | (0.70–1.10 mmol/L) | 1.16 ± 0.26 |
| Parathyroid hormone | (120–300 pg/mL) | 234.94 ± 271.53 |
| Albumin | (35–52 g/L) | 36.96 ± 3.26 |
| Urea before hemodialysis | (3.0–8.0 mmol/L) | 21.45± 5.06 |
| Urea after hemodialysis | (3.0–8.0 mmol/L) | 7.59 ±2.93 |
| Creatinine before hemodialysis | (49–106 μmol/L) | 772.59 ± 512.59 |
| Creatinine after hemodialysis | (49–106 μmol/L) | 324.36 ± 106.99 |
| NTproBNP before hemodialysis | (≥7200 pg/mL) | 17,491.20 ± 34,341.10 |
| NTproBNP after hemodialysis | (≥7200 pg/mL) | 14,575.93 ± 34,478.69 |
| Troponin before hemodialysis | men ≤ 0.03 woman ≤ 0.01 |
0.02 ± 0.01 |
| Troponin after hemodialysis | men ≤ 0.03 woman ≤ 0.01 |
0.02 ± 0.01 |
| Glomerular filtration rate | 0–15 mL/min | 10.94 ± 3.37 |
Continuous variables are presented as mean ± SD. ESRD, end-stage renal disease; NTproBNP, N-terminal proBrain Natriuretic Peptide.